PubMed=3434911; DOI=10.2460/ajvr.1987.48.11.1642
Wolfe L.G., Oliver J.L. 3rd, Smith B.B., Toivio-Kinnucan M.A., Powers R.D., Brawner W.R., Henderson R.A., Hankes G.H.
Biologic characterization of canine melanoma cell lines.
Am. J. Vet. Res. 48:1642-1648(1987)

PubMed=8239507
Ahern T.E., Bird R.C., Church Bird A.E., Wolfe L.G.
Overexpression of c-erbB-2 and c-myc but not c-ras, in canine melanoma cell lines, is associated with metastatic potential in nude mice.
Anticancer Res. 13:1365-1371(1993)

PubMed=11467477; DOI=10.1354/vp.38-4-427
Koenig A., Wojcieszyn J., Weeks B.R., Modiano J.F.
Expression of S100a, vimentin, NSE, and melan A/MART-1 in seven canine melanoma cells lines and twenty-nine retrospective cases of canine melanoma.
Vet. Pathol. 38:427-435(2001)

PubMed=12944992; DOI=10.1038/sj.cgt.7700625
Bianco S.R., Sun J., Fosmire S.P., Hance K.W., Padilla M.L., Ritt M.G., Getzy D.M., Duke R.C., Withrow S.J., Lana S., Matthiesen D.T., Dow S.W., Bellgrau D., Cutter G.R., Helfand S.C., Modiano J.F.
Enhancing antimelanoma immune responses through apoptosis.
Cancer Gene Ther. 10:726-736(2003)